Baltimore, MD3 Active Studies

Gallbladder Cancer Clinical Trials in Baltimore, MD

Find 3 actively recruiting gallbladder cancer clinical trials in Baltimore, MD. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
208
Enrolling

Recruiting Gallbladder Cancer Studies in Baltimore

About Gallbladder Cancer Clinical Trials in Baltimore

Gallbladder cancer and bile duct cancers (cholangiocarcinoma) are rare cancers of the biliary system. They are often diagnosed at advanced stages due to vague symptoms. Treatment includes surgery, chemotherapy, and targeted therapy based on genetic mutations.

There are currently 3 gallbladder cancer clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 208 participants. Research is being sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, University of Maryland, Baltimore. Clinical trial participation is free and participants receive study-related medical care at no cost.

Gallbladder Cancer Clinical Trials in Baltimore — FAQ

Are there gallbladder cancer clinical trials in Baltimore?

Yes, there are 3 gallbladder cancer clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What gallbladder cancer treatments are being tested?

The 3 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for gallbladder cancer.

Data updated July 13, 2026 from ClinicalTrials.gov